Ethical Limits On Manipulating Cell Division.
Ethical Limits on Manipulating Cell Division
1. Introduction
Cell division is the natural process through which one cell divides to form new cells. It is essential for growth, healing, reproduction and replacement of damaged tissues. Manipulating cell division means deliberately changing the speed, timing or pattern of this process through medicines, genetic techniques or biotechnology.
Such manipulation can help treat cancer, repair damaged organs and manage certain diseases. However, uncontrolled changes may cause tumours, genetic abnormalities, infertility or permanent damage. Therefore, cell division must be controlled by ethical and legal safeguards.
2. Meaning and purpose
Cell division mainly occurs through two processes: mitosis, which produces two body cells, and meiosis, which produces reproductive cells. Scientific methods may increase, slow down or stop these processes.
The main purposes include:
Promoting tissue repair and wound healing.
Controlling the growth of cancer cells.
Developing regenerative medicines.
Studying genetic diseases.
Improving understanding of ageing and cell damage.

Interphase
DNA has been copied before mitosis, but it still remains uncondensed inside one nucleus.
Give feedback
3. Ethical principles
a. Human dignity: Cell manipulation must respect the dignity and physical integrity of every person. Scientific progress cannot justify unnecessary harm.
b. Informed consent: Patients must receive clear information about possible benefits, risks and long-term effects before treatment.
c. Safety: Researchers must examine whether altered cell division may cause cancer, abnormal growth or damage to healthy tissues.
d. Justice and equality: Advanced treatments should not be available only to wealthy individuals. Access should be fair and non-discriminatory.
e. Protection of future generations: Manipulation involving reproductive cells or embryos requires special caution because its effects may extend beyond the person receiving treatment.
4. Indian legal framework
Article 21 of the Indian Constitution protects life and personal liberty. It includes the right to dignity, bodily autonomy and privacy. Any medical intervention affecting cell division must respect these rights.
The Indian Council of Medical Research (ICMR) National Ethical Guidelines for Biomedical and Health Research Involving Human Participants, 2017, provide standards for informed consent, risk assessment and ethical review.
The Drugs and Cosmetics Act, 1940, and applicable rules regulate relevant drugs and clinical trials. The Consumer Protection Act, 2019, may also provide remedies where defective medical services or negligence cause harm.
Research involving human participants should receive appropriate ethics committee review and follow applicable regulatory requirements.
5. Relevant case laws
1. Samira Kohli v. Dr. Prabha Manchanda (2008) 2 SCC 1
The Supreme Court explained that valid medical consent must be voluntary and based on adequate information. A doctor cannot perform an additional procedure without proper consent, except in limited emergency circumstances. This principle applies to treatments that manipulate cell division.
2. Justice K.S. Puttaswamy v. Union of India (2017) 10 SCC 1
The Supreme Court recognised privacy as a fundamental right, including personal autonomy and control over personal information. This is relevant when genetic and cellular information is collected or used in research.
3. Jacob Mathew v. State of Punjab (2005) 6 SCC 1
The Court explained the legal principles governing medical negligence and the standard of reasonable professional care. Researchers and medical professionals must follow accepted safety standards when using treatments that alter cell growth.
4. Common Cause v. Union of India (2018) 5 SCC 1
The Court recognised dignity and individual autonomy in end-of-life decisions. Although the case did not concern cell manipulation, its constitutional principles support respect for a patient's informed medical choices.
6. Major ethical challenges
a. Uncontrolled cell growth: Excessive stimulation of cell division may lead to abnormal tissue growth or cancer.
b. Genetic damage: Changes in cellular processes may produce mutations that affect the normal functioning of the body.
c. Long-term uncertainty: Some treatments may have effects that appear only after several years. This creates difficulties in evaluating their safety.
d. Commercial misuse: Companies may promote unproven cellular treatments for profit without sufficient scientific evidence.
e. Vulnerable participants: Children, patients with serious illnesses and individuals unable to give informed consent require additional protection.
7. Preventive measures
Conduct proper laboratory testing and clinical trials before approving treatments.
Obtain informed consent from every participant.
Require independent ethics committee approval for human research.
Monitor patients for long-term complications.
Prevent unauthorised genetic and cellular experiments.
Ensure that treatment claims are supported by reliable scientific evidence.
Provide legal remedies to individuals harmed by unsafe procedures.
8. Conclusion
Manipulating cell division has important medical benefits, particularly in cancer treatment, tissue repair and regenerative medicine. However, uncontrolled changes can create serious risks to human health and dignity. Indian constitutional protections, medical regulations and judicial principles provide safeguards for responsible scientific development. Therefore, cell division should be manipulated only for legitimate medical or scientific purposes, with proper consent, safety testing, ethical supervision and accountability.

comments